Agathos Selected for Dreamit HealthTech's Cohort
Dreamit Ventures has selected Agathos along with seven other startups for the fall 2018 class of its HealthTech cohort. See the MedCity announcement.
Dreamit is a globally recognized venture fund and accelerator designed for pre-Series A companies seeking to accelerate growth and close a Series A round within the next six months. Dreamit’s health tech portfolio includes successful startups, such as: Narrative Dx, Eko Device, and Redox .
The HealthTech cohort centers on a 2-week customer roadshow where Agathos will present to health system executives to initiate partnerships, discuss pilots, and gain customers. Following will be a 2-week investor roadshow focused on kicking off a Series A raise.
In the customer roadshow, Agathos will present to executives at leading health systems in New York, Pennsylvania, Florida, and other locations including: Mount Sinai, Montefiore, Penn Medicine, CHOP, Jefferson Health, Geisinger, Temple Health, St. Luke’s University Health Network, Tampa General Hospital, BayCare, Children’s Hospital of Los Angeles, and Intermountain Healthcare.
The investor roadshow is a curated set of 1-on-1 meetings at leading VCs and healthcare-focused funds in the Bay Area, New York City, and Boston. Dreamit has an extensive network of over 1,000 venture capitalists looking for digital health investments, including: Northwest Venture Partners, McKesson Ventures, and Andreesen Horowitz.
Agathos is thrilled to be part of Dreamit’s health tech program!